BEAM
#1719
Beam Therapeutics Inc. - Common Stock
29.3 2 USD
-0.04%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-3.81%
Variación mensual
+8.87%
Variación en los últimos 6 meses
+7.05%
Cambio anual
+81.10%
Cierres anteriores
30.4 8
Open
29.3 2
Mínimo
29.3 2
Máximo
29.3 2
Volumen
155
Financials
- Market Capitalization 3.03 B
- Employee 540
- Founded 2017
- CEO John Evans
- Website www.beamtx.com
- Headquarter Delaware, United States
- FIGI BBG00KXC8646
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-51.22
Relación precio/flujo de caja
22
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1703 |  IRON Disc Medicine, Inc. - Common Stock | 80.03 USD | -3.05% | +0.19% | +2.05% | +34.46% | 3.07 B USD | ||
| 1704 |  CLDX Celldex Therapeutics, Inc. - Common Stock | 39.12 USD | -3.31% | -2.59% | +1.61% | +43.61% | 3.07 B USD | ||
| 1727 |  ARQT Arcutis Biotherapeutics, Inc. - Common stock | 23.78 USD | -4.38% | -4.11% | -14.37% | +53.82% | 2.99 B USD | ||
| 1741 |  ZLAB Zai Lab Limited - American Depositary Shares | 26.08 USD | -2.76% | +2.35% | +43.06% | -2.29% | 2.93 B USD |